Your Embryos Aren't Implanting. Your Genes May Explain Why.

MTHFR is your cell’s master methylation enzyme. It controls whether your cells can attach chemical tags to DNA that turn genes on and off. During embryo development, these tags are critical. They tell cells whether to become heart tissue, brain tissue, or reproductive tissue. They’re especially important during the first few days after fertilization, when your embryo is making the decision to implant.

The MTHFR C677T variant, carried by roughly 40% of people with European ancestry, reduces this enzyme’s efficiency by 40-70%. That means your cells are producing fewer methyl groups than they should be. Your embryo may develop normally on the outside but have impaired gene expression on the inside, making implantation signaling incomplete.

You feel this as repeated embryos that look perfect morphologically but fail to implant, or implant but don’t progress. Your embryologist says the embryos look beautiful. Your body agrees they look beautiful. But your embryo’s epigenetic machinery is scrambled, and it can’t send the right signals to your endometrium at the right time.

The follicle-stimulating hormone receptor (FSHR) is the lock on your ovarian cells. FSH is the key. When FSH finds FSHR, your ovaries respond by growing follicles. Without FSHR function, FSH stimulation does nothing. You can inject as much FSH as you want, and your ovaries simply won’t listen.

The FSHR N680S variant (the S/S genotype) is present in roughly 10-15% of women. People with this variant are poor responders to FSH stimulation. Your ovaries need much higher doses of FSH to produce the same number of follicles that normal responders achieve with standard doses. If your fertility clinic is using standard stimulation protocols, they may be severely under-stimulating your ovaries.

You experience this as slow follicle growth, fewer eggs retrieved despite normal baseline hormone levels, and repeated cancelled or converted cycles. Your doctor keeps increasing the dose, but your ovaries seem to respond inconsistently. This isn’t poor egg quality. It’s poor reception of the signal.

Estrogen receptor 1 (ESR1) is the sensor that tells your endometrium how to prepare for implantation. When estrogen binds to ESR1, your endometrium thickens, becomes more vascularized, and produces the proteins that create a welcoming environment for an embryo. Without functional ESR1, your endometrium can’t interpret the estrogen signal, no matter how much estrogen you have.

The ESR1 PvuII and XbaI variants affect how efficiently estrogen binds to this receptor. Roughly 40% of women carry at least one of these variants. Your endometrium may have normal thickness and normal hormone levels but be completely unable to generate the molecular environment that allows implantation to begin.

You experience this as euthyroid implantation failure: good embryos, good lining thickness, good progesterone levels, and yet implantation never starts. Your endometrium looks right on ultrasound but is biochemically unprepared.

The catechol-O-methyltransferase (COMT) enzyme is your body’s estrogen disposal system. It grabs estrogen molecules that have already done their job and breaks them down into inactive forms that you can excrete. Without efficient COMT, estrogen levels stay elevated even when biologically they should be dropping. This is especially problematic in the luteal phase, when high estrogen interferes with progesterone signaling.

The COMT Val158Met variant creates a slow version of this enzyme. Roughly 25% of people with European ancestry are homozygous for the slow version. Your estrogen levels stay 2-3 times higher than they should be during the luteal phase, suppressing progesterone receptor function and preventing the endometrium from transitioning into an implantation-ready state.

You experience this as a luteal phase that feels normal but biochemically is still in follicular phase. Your progesterone level looks good on paper, but your endometrium can’t respond to it because estrogen is still screaming louder. High estrogen is also strongly associated with endometriosis, which frequently co-occurs with implantation failure.

The vitamin D receptor (VDR) is your immune system’s calibration tool. It tells your immune cells when to tolerate foreign tissue (like an implanting embryo) and when to attack it. During implantation, your immune system must shift into a profoundly tolerant state. Your embryo is, genetically, 50% foreign. Without proper VDR function, your immune system treats your embryo like an infection.

The VDR FokI variant affects the length of the VDR protein and how efficiently it functions. People with the short form have roughly 1.7 times higher VDR activity, while people with the long form have lower activity. Long-form carriers have impaired vitamin D signaling and a much more reactive immune response to the implanting embryo, leading to subclinical rejection even when no immune markers are obviously elevated.

You experience this as implantation that starts but doesn’t progress, or very early losses that feel like failed implantation. Your bloodwork shows no elevated natural killer cells or thrombophilia, yet implantation fails anyway. Your immune system is trained to reject.

The fragile X mental retardation 1 gene (FMR1) doesn’t just affect neurodevelopment. It also controls ovarian function. Women who carry premutation alleles in FMR1 experience accelerated ovarian aging, typically decades before natural menopause. This happens silently. Your FSH and antral follicle counts may look normal now, but your ovarian reserve is declining much faster than your age would predict.

The FMR1 premutation is carried by roughly 1 in 250 women. People with premutation alleles (55-200 CGG repeats) have a 50-70% lifetime risk of premature ovarian insufficiency (POI). If you’re under 40 and have had multiple failed cycles, FMR1 premutation status may explain why: your eggs are being depleted faster than a standard age-based calculation would predict.

You experience this as unexpectedly poor egg quantity and quality for your age, FSH levels that creep upward despite being young, and a sense that your ovarian reserve is vanishing faster than it should be. This isn’t lifestyle or environmental. Your genes are programming your ovarian clock to run fast.